诱导性氧化合成酶的缺陷可以缓解皮肤纤维化和硬化皮质炎症的炎症
Jing Luo1, Mingwei Li1, Di Zhao1
1Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin 300070, China.
International immunopharmacology
|January 17, 2026
概括
诱导性氧化合成酶 (iNOS) 通过激活纤维细胞和促进炎症,驱动着硬化皮肤病的进展. 在小鼠模型中,抑制iNOS显著降低了疾病的严重程度,这表明iNOS是治疗点.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 纤维性疾病 纤维性疾病
- 结合组织疾病 结合组织疾病
背景情况:
- 硬化症涉及慢性炎症和皮肤纤维化,由于纤维细胞激活和原沉积.
- 角质细胞,免疫细胞和纤维细胞之间的细胞交叉是硬化皮肤病原发生的关键.
- 诱导性氧化合成酶 (iNOS) 在硬化皮肤病变中被上调,但其具体作用尚不清楚.
研究的目的:
- 阐明诱导性氧化合成酶 (iNOS) 在硬化肌病进展中的特定作用.
- 为了研究针对INOS的治疗潜力,在硬化皮肤病模型中进行向.
主要方法:
- 采用了白胺诱导性硬化皮肤病小鼠模型,比较了野生型 (WT) 和iNOS淘汰 (iNOS KO) 的小鼠.
- 评估炎症因子表达和免疫细胞透 (角质细胞和中性粒细胞).
- 用TNF-α和IL-1β刺激纤维细胞,以评估iNOS删除对纤维细胞激活的影响.
主要成果:
- 缺乏iNOS显著缓解了硬化皮肤病的进展,减少了炎症和中性粒细胞的透.
- 删除因 keratinocyte 和中性粒细胞衍生因素诱导的 iNOS 减弱纤维细胞激活.
- iNOS 抑制剂显著降低了硬化皮肤病变的严重程度.
结论:
- 诱导性氧化合成酶 (iNOS) 在驱动性硬化肌病的发病过程中发挥着关键作用.
- 向iNOS是一个有前途的治疗策略,用于管理多发性硬皮症.
相关概念视频
Nitric Oxide Signaling Pathway
6.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.2K
NF-κB-dependent Signaling Pathway
9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.8K


